Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study

By Bonneterre J.   Campone M.   Koralewski P.   Blasinska-Morawiec M.   Deporte-Fety R.   Chatelut E.   Leger F.   Longerey B.   Ecochard L.   Douville I.  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 365-373

Springer Publishing Company

Access to resources Recommend Favorite

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study

By Delva R.   Pienkowski T.   Tubiana N.   Vanhoefer U.   Longerey B.   Douville I.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 703-709

Springer Publishing Company

Access to resources Recommend Favorite

MFL-P chemotherapy for pretreated metastatic Breast Cancer patients: A regimen with triple biochemical modulation by MTX-5FU, LV-5FU and 5FU-CDDP

By Kan Norimichi   Honda Goro  

Breast Cancer, Vol. 6, Iss. 3, 1999-07 ,pp. : 187-191

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite